These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 12181274

  • 1. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K, Oda Y, Sakamoto A, Saito T, Tamiya S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
    [Abstract] [Full Text] [Related]

  • 2. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
    Park HR, Jung WW, Bertoni F, Bacchini P, Park JH, Kim YW, Park YK.
    Pathol Res Pract; 2004 Aug; 200(6):439-45. PubMed ID: 15310147
    [Abstract] [Full Text] [Related]

  • 3. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [Abstract] [Full Text] [Related]

  • 4. p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate.
    Lonardo F, Ueda T, Huvos AG, Healey J, Ladanyi M.
    Cancer; 1997 Apr 15; 79(8):1541-7. PubMed ID: 9118036
    [Abstract] [Full Text] [Related]

  • 5. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
    Hisaoka M, Morimitsu Y, Hashimoto H, Ishida T, Mukai H, Satoh H, Motoi T, Machinami R.
    Am J Surg Pathol; 1999 Dec 15; 23(12):1480-92. PubMed ID: 10584701
    [Abstract] [Full Text] [Related]

  • 6. MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma.
    Reid AH, Tsai MM, Venzon DJ, Wright CF, Lack EE, O'Leary TJ.
    Diagn Mol Pathol; 1996 Mar 15; 5(1):65-73. PubMed ID: 8919547
    [Abstract] [Full Text] [Related]

  • 7. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H, Nakayama T, Murakami H, Hosaka T, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Sasaki MS, Toguchida J.
    Anticancer Res; 1998 Mar 15; 18(4A):2317-21. PubMed ID: 9703873
    [Abstract] [Full Text] [Related]

  • 8. Osteosarcoma versus malignant fibrous histiocytoma of bone in patients older than 40 years. A clinicopathologic and immunohistochemical analysis with special reference to malignant fibrous histiocytoma-like osteosarcoma.
    Naka T, Fukuda T, Shinohara N, Iwamoto Y, Sugioka Y, Tsuneyoshi M.
    Cancer; 1995 Sep 15; 76(6):972-84. PubMed ID: 8625223
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL.
    Genes Chromosomes Cancer; 2010 Jun 15; 49(6):518-25. PubMed ID: 20196171
    [Abstract] [Full Text] [Related]

  • 10. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance.
    Molina P, Pellín A, Navarro S, Boix J, Carda C, Llombart-Bosch A.
    Virchows Arch; 1999 Dec 15; 435(6):596-605. PubMed ID: 10628802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
    Coindre JM, Hostein I, Maire G, Derré J, Guillou L, Leroux A, Ghnassia JP, Collin F, Pedeutour F, Aurias A.
    J Pathol; 2004 Jul 15; 203(3):822-30. PubMed ID: 15221942
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
    Szadowska A, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    Pol J Pathol; 1998 Jul 15; 49(1):15-21. PubMed ID: 9640970
    [Abstract] [Full Text] [Related]

  • 20. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
    Guérin M, Thariat J, Ouali M, Bouvier C, Decouvelaere AV, Cassagnau E, Aubert S, Lepreux S, Coindre JM, Valmary-Degano S, Larousserie F, Meilleroux J, Projetti F, Stock N, Galant C, Marie B, Peyrottes I, de Pinieux G, Gomez-Brouchet A.
    Hum Pathol; 2016 Apr 15; 50():70-8. PubMed ID: 26997440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.